Related Experiment Video

Updated: Aug 16, 2025

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells
08:54

An Immunofluorescent Method for Characterization of Barrett’s Esophagus Cells

Published on: July 20, 2014

14.1K

Slit2 signaling stimulates Ewing sarcoma growth

Kruthi Suvarna1, Panneerselvam Jayabal1, Xiuye Ma1

  • 1Greehey Children's Cancer Research Institute, The University of Texas Health Science Center, San Antonio, TX 78229-3900, USA.

Genes & Cancer
|December 19, 2022
PubMed

Insights

New research reveals that the Slit2 signaling pathway promotes pediatric Ewing sarcoma growth. Targeting Slit2 or its receptors, Robo1 and Robo2, may offer novel therapeutic strategies for this challenging bone and soft tissue cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Genetics

Background:

  • Ewing sarcoma is a pediatric bone and soft tissue cancer driven by EWS::ETS fusions, primarily EWS::FLI1.
  • Current treatments for metastatic or recurrent Ewing sarcoma have limited efficacy, necessitating novel therapeutic approaches.
  • The primary driver, EWS::FLI1, is difficult to target directly, prompting research into its downstream molecular vulnerabilities.

Purpose of the Study:

  • To investigate the role of Slit2 signaling in Ewing sarcoma pathogenesis.
  • To identify potential therapeutic targets by understanding how EWS::FLI1 influences Ewing sarcoma growth.

Main Methods:

  • Analysis of EWS::FLI1 binding to the Slit2 gene promoter.
  • Investigating the effect of EWS::FLI1 on Slit2 expression.
  • Examining the impact of Slit2 and its receptors (Robo1, Robo2) on Ewing sarcoma cell growth through gene silencing experiments.

Main Results:

  • EWS::FLI1 directly induces Slit2 expression by binding to its promoter.
  • Slit2 inactivation of cdc42 and stabilization of BAF chromatin remodeling complexes enhance EWS::FLI1 transcriptional activity.
  • Silencing Slit2, Robo1, or Robo2 significantly inhibited both anchorage-dependent and independent growth of Ewing sarcoma cells.

Conclusions:

  • Slit2 signaling is a critical pathway that promotes Ewing sarcoma growth.
  • The Slit2-Robo pathway represents a promising novel therapeutic target for Ewing sarcoma.
Keywords:
EWS::FLI1Ewing sarcomaRoboSlit2cdc42

More Related Videos

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis12:03

In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis

Published on: December 9, 2016

12.5K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

3.7K

Related Concept Videos

Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.4K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.8K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.3K